FDA Inspection 1012248 — Fuan Pharmaceutical Group Chongqing Bosen Pharma. Co., LTD
The FDA completed an inspection of Fuan Pharmaceutical Group Chongqing Bosen Pharma. Co., LTD on May 12, 2017 in Zhongqing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zhongqing (China)